These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 38160042)

  • 1. Clinical implications of VUS reclassification in a single-centre series from application of ACMG/AMP classification rules specified for
    Innella G; Ferrari S; Miccoli S; Luppi E; Fortuno C; Parsons MT; Spurdle AB; Turchetti D
    J Med Genet; 2024 Apr; 61(5):483-489. PubMed ID: 38160042
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence-based recommendations for gene-specific ACMG/AMP variant classification from the ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel.
    Parsons MT; de la Hoya M; Richardson ME; Tudini E; Anderson M; Berkofsky-Fessler W; Caputo SM; Chan RC; Cline MS; Feng BJ; Fortuno C; Gomez-Garcia E; Hadler J; Hiraki S; Holdren M; Houdayer C; Hruska K; James P; Karam R; Leong HS; Martins A; Mensenkamp AR; Monteiro AN; Nathan V; O'Connor R; Pedersen IS; Pesaran T; Radice P; Schmidt G; Southey M; Tavtigian S; Thompson BA; Toland AE; Turnbull C; Vogel MJ; Weyandt J; Wiggins GAR; Zec L; Couch FJ; Walker LC; Vreeswijk MPG; Goldgar DE; Spurdle AB
    Am J Hum Genet; 2024 Sep; 111(9):2044-2058. PubMed ID: 39142283
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reinterpretation of BRCA1 and BRCA2 variants of uncertain significance in patients with hereditary breast/ovarian cancer using the ACMG/AMP 2015 guidelines.
    So MK; Jeong TD; Lim W; Moon BI; Paik NS; Kim SC; Huh J
    Breast Cancer; 2019 Jul; 26(4):510-519. PubMed ID: 30725392
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reclassification of
    Lee JS; Oh S; Park SK; Lee MH; Lee JW; Kim SW; Son BH; Noh DY; Lee JE; Park HL; Kim MJ; Cho SI; Lee YK; Park SS; Seong MW
    J Med Genet; 2018 Dec; 55(12):794-802. PubMed ID: 30415210
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification of BRCA2 Variants of Uncertain Significance (VUS) Using an ACMG/AMP Model Incorporating a Homology-Directed Repair (HDR) Functional Assay.
    Hu C; Susswein LR; Roberts ME; Yang H; Marshall ML; Hiraki S; Berkofsky-Fessler W; Gupta S; Shen W; Dunn CA; Huang H; Na J; Domchek SM; Yadav S; Monteiro ANA; Polley EC; Hart SN; Hruska KS; Couch FJ
    Clin Cancer Res; 2022 Sep; 28(17):3742-3751. PubMed ID: 35736817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges in periodic revision of genetic testing results: Comparison of the main classification guidelines and report of a retrospective analysis involving BRCA1/BRCA2 variants of uncertain significance.
    Andreis TF; de Souza KIW; Vieira IA; Alemar B; Sinigaglia M; de Araújo Rocha YM; Artigalás O; Bittar C; Oliveira Netto CB; Ashton-Prolla P; Rosset C
    Gene; 2023 Apr; 862():147281. PubMed ID: 36775216
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Classification of 101 BRCA1 and BRCA2 variants of uncertain significance by cosegregation study: A powerful approach.
    Caputo SM; Golmard L; Léone M; Damiola F; Guillaud-Bataille M; Revillion F; Rouleau E; Derive N; Buisson A; Basset N; Schwartz M; Vilquin P; Garrec C; Privat M; Gay-Bellile M; Abadie C; Abidallah K; Airaud F; Allary AS; Barouk-Simonet E; Belotti M; Benigni C; Benusiglio PR; Berthemin C; Berthet P; Bertrand O; Bézieau S; Bidart M; Bignon YJ; Birot AM; Blanluet M; Bloucard A; Bombled J; Bonadona V; Bonnet F; Bonnet-Dupeyron MN; Boulaire M; Boulouard F; Bouras A; Bourdon V; Brahimi A; Brayotel F; Bressac de Paillerets B; Bronnec N; Bubien V; Buecher B; Cabaret O; Carriere J; Chiesa J; Chieze-Valéro S; Cohen C; Cohen-Haguenauer O; Colas C; Collonge-Rame MA; Conoy AL; Coulet F; Coupier I; Crivelli L; Cusin V; De Pauw A; Dehainault C; Delhomelle H; Delnatte C; Demontety S; Denizeau P; Devulder P; Dreyfus H; d'Enghein CD; Dupré A; Durlach A; Dussart S; Fajac A; Fekairi S; Fert-Ferrer S; Fiévet A; Fouillet R; Mouret-Fourme E; Gauthier-Villars M; Gesta P; Giraud S; Gladieff L; Goldbarg V; Goussot V; Guibert V; Guillerm E; Guy C; Hardouin A; Heude C; Houdayer C; Ingster O; Jacquot-Sawka C; Jones N; Krieger S; Lacoste S; Lallaoui H; Larbre H; Laugé A; Le Guyadec G; Le Mentec M; Lecerf C; Le Gall J; Legendre B; Legrand C; Legros A; Lejeune S; Lidereau R; Lignon N; Limacher JM; Doriane Livon ; Lizard S; Longy M; Lortholary A; Macquere P; Mailliez A; Malsa S; Margot H; Mari V; Maugard C; Meira C; Menjard J; Molière D; Moncoutier V; Moretta-Serra J; Muller E; Nevière Z; Nguyen Minh Tuan TV; Noguchi T; Noguès C; Oca F; Popovici C; Prieur F; Raad S; Rey JM; Ricou A; Salle L; Saule C; Sevenet N; Simaga F; Sobol H; Suybeng V; Tennevet I; Tenreiro H; Tinat J; Toulas C; Turbiez I; Uhrhammer N; Vande Perre P; Vaur D; Venat L; Viellard N; Villy MC; Warcoin M; Yvard A; Zattara H; Caron O; Lasset C; Remenieras A; Boutry-Kryza N; Castéra L; Stoppa-Lyonnet D
    Am J Hum Genet; 2021 Oct; 108(10):1907-1923. PubMed ID: 34597585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Large-scale application of ClinGen-InSiGHT APC-specific ACMG/AMP variant classification criteria leads to substantial reduction in VUS.
    Yin X; Richardson M; Laner A; Shi X; Ognedal E; Vasta V; Hansen TVO; Pineda M; Ritter D; de Dunnen J; Hassanin E; Lin WL; Borras E; Krahn K; Nordling M; Martins A; Mahmood K; Nadeau E; Beshay V; Tops C; Genuardi M; Pesaran T; Frayling IM; Capellá G; Latchford A; Tavtigian SV; Maj C; Plon SE; Greenblatt MS; Macrae FA; Spier I; Aretz S
    Am J Hum Genet; 2024 Nov; 111(11):2427-2443. PubMed ID: 39357517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of proactive high-throughput functional assay data on BRCA1 variant interpretation in 3684 patients with breast or ovarian cancer.
    Kim HK; Lee EJ; Lee YJ; Kim J; Kim Y; Kim K; Lee SW; Chang S; Lee YJ; Lee JW; Lee W; Chun S; Son BH; Jung KH; Kim YM; Min WK; Ahn SH
    J Hum Genet; 2020 Mar; 65(3):209-220. PubMed ID: 31907386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Disease-specific ACMG/AMP guidelines improve sequence variant interpretation for hearing loss.
    Patel MJ; DiStefano MT; Oza AM; Hughes MY; Wilcox EH; Hemphill SE; Cushman BJ; Grant AR; Siegert RK; Shen J; Chapin A; Boczek NJ; Schimmenti LA; Nara K; Kenna M; Azaiez H; Booth KT; Avraham KB; Kremer H; Griffith AJ; Rehm HL; Amr SS; Tayoun ANA;
    Genet Med; 2021 Nov; 23(11):2208-2212. PubMed ID: 34230634
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline ATM sequence variants.
    Richardson ME; Holdren M; Brannan T; de la Hoya M; Spurdle AB; Tavtigian SV; Young CC; Zec L; Hiraki S; Anderson MJ; Walker LC; McNulty S; Turnbull C; Tischkowitz M; Schon K; Slavin T; Foulkes WD; Cline M; Monteiro AN; Pesaran T; Couch FJ
    Am J Hum Genet; 2024 Nov; 111(11):2411-2426. PubMed ID: 39317201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specifications of the ACMG/AMP Variant Classification Guidelines for Germline
    Hatton JN; Frone MN; Cox HC; Crowley SB; Hiraki S; Yokoyama NN; Abul-Husn NS; Amatruda JF; Anderson MJ; Bofill-De Ros X; Carr AG; Chao EC; Chen KS; Gu S; Higgs C; Machado J; Ritter D; Schultz KA; Soper ER; Wu MK; Mester JL; Kim J; Foulkes WD; Witkowski L; Stewart DR
    Hum Mutat; 2023; 2023():. PubMed ID: 38084291
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of BRCA1/2 variants of unknown significance in the prospective Korean Hereditary Breast Cancer study.
    Kim JH; Park S; Park HS; Park JS; Lee ST; Kim SW; Lee JW; Lee MH; Park SK; Noh WC; Choi DH; Han W; Jung SH
    Sci Rep; 2021 Apr; 11(1):8485. PubMed ID: 33875706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reclassification of
    Ha HI; Ryu JS; Shim H; Kong SY; Lim MC
    J Gynecol Oncol; 2020 Nov; 31(6):e83. PubMed ID: 33078592
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene-specific ACMG/AMP classification criteria for germline APC variants: Recommendations from the ClinGen InSiGHT Hereditary Colorectal Cancer/Polyposis Variant Curation Expert Panel.
    Spier I; Yin X; Richardson M; Pineda M; Laner A; Ritter D; Boyle J; Mur P; Hansen TVO; Shi X; Mahmood K; Plazzer JP; Ognedal E; Nordling M; Farrington SM; Yamamoto G; Baert-Desurmont S; Martins A; Borras E; Tops C; Webb E; Beshay V; Genuardi M; Pesaran T; Capellá G; Tavtigian SV; Latchford A; Frayling IM; Plon SE; Greenblatt M; Macrae FA; Aretz S;
    Genet Med; 2024 Feb; 26(2):100992. PubMed ID: 37800450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Specifications of the ACMG/AMP variant curation guidelines for the analysis of germline CDH1 sequence variants.
    Lee K; Krempely K; Roberts ME; Anderson MJ; Carneiro F; Chao E; Dixon K; Figueiredo J; Ghosh R; Huntsman D; Kaurah P; Kesserwan C; Landrith T; Li S; Mensenkamp AR; Oliveira C; Pardo C; Pesaran T; Richardson M; Slavin TP; Spurdle AB; Trapp M; Witkowski L; Yi CS; Zhang L; Plon SE; Schrader KA; Karam R
    Hum Mutat; 2018 Nov; 39(11):1553-1568. PubMed ID: 30311375
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Retrospective reinterpretation and reclassification of BRCA1/2 variants from Chinese population.
    Li D; Shi Y; Li A; Cao D; Su H; Yang H; Zhi Q; Yang Y; Lan Z; Zhou T; You X; Hu G
    Breast Cancer; 2020 Nov; 27(6):1158-1167. PubMed ID: 32566972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Study on the Retrospective Reinterpretation of BRCA1 and BRCA2 Variants.
    Kim JJ; Kim DJ; Nam EJ; Song KE; Ham JY; Kim YK; Lee NY
    Clin Lab; 2024 Apr; 70(4):. PubMed ID: 38623660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Variant Classification for Pompe disease; ACMG/AMP specifications from the ClinGen Lysosomal Diseases Variant Curation Expert Panel.
    Goldstein JL; McGlaughon J; Kanavy D; Goomber S; Pan Y; Deml B; Donti T; Kearns L; Seifert BA; Schachter M; Son RG; Thaxton C; Udani R; Bali D; Baudet H; Caggana M; Hung C; Kyriakopoulou L; Rosenblum L; Steiner R; Pinto E Vairo F; Wang Y; Watson M; Fernandez R; Weaver M; Clarke L; Rehder C
    Mol Genet Metab; 2023; 140(1-2):107715. PubMed ID: 37907381
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Variant classification changes over time in BRCA1 and BRCA2.
    Mighton C; Charames GS; Wang M; Zakoor KR; Wong A; Shickh S; Watkins N; Lebo MS; Bombard Y; Lerner-Ellis J
    Genet Med; 2019 Oct; 21(10):2248-2254. PubMed ID: 30971832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.